-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
- Transcode Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$156K, a 1616% decline year-over-year.
- Transcode Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$261K, a 121% decline year-over-year.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $872K, a 18.4% decline from 2022.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.07M.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$692K, a 57.2% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)